Retireful, LLC Eli Lilly & CO Transaction History

Retireful, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $838,674 - $1.05 Million	1,157 New	1,157 $1.05 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $436,432 - $514,497	831 Added 28.84%	3,712 $2.16 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $1.25 Million - $1.73 Million	2,881 New	2,881 $1.55 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $875,044 - $1.03 Million	2,817 New	2,817 $967,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Retireful, LLC, based on Form 13F filings with the SEC.

Stay updated on Retireful, LLC with notifications on news.